Methods for treating anemia using an actriib ligand trap and fedratinib
US-2023181690-A1 · Jun 15, 2023 · US
This page is not indexed by search engines while we improve data quality.
Laadem Abderrahmane patents
Laadem Abderrahmane is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Laadem Abderrahmane |
| Total patents | 7 |
| First publication | Dec 21, 2017 |
| Latest publication | Jun 15, 2023 |
Notable patents
Publications ranked by popularity score, then publication date.
Activin-actrii antagonists and uses for treating anemia
US-2023142386-A1 · May 11, 2023 · US
Activin-ActRII antagonists and uses for treating anemia
US-11471510-B2 · Oct 18, 2022 · US
TREATMENT OF ANEMIA DUE TO VERY LOW, LOW, OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES IN SUBJECTS WITH RING SIDEROBLASTS USING ACTIVIN-ACTRll LIGAND TRAPS
US-2021346464-A1 · Nov 11, 2021 · US
Methods for treating myeloproliferative neoplasm-associated myelofibrosis and anemia
US-2020101134-A1 · Apr 2, 2020 · US
Treatment of beta-thalassemia using actrii ligand traps
US-2018125928-A1 · May 10, 2018 · US
Activin-actrii antagonists and uses for treating anemia
US-2017360887-A1 · Dec 21, 2017 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Celgene Corp | 7 |
| Acceleron Pharma Inc | 5 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K38/179 | 7 |
| C07K14/71 | 6 |
| C07K2319/30 | 6 |
| A61P7/06 | 6 |
| G01N33/49 | 3 |